Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FM-VP4 highlighted at recent AHA conference as novel therapy for cardiovascular disease

May 15, 2001

Postprandial TG-lowering effects of NK-104 investigated in animal model

May 15, 2001

6-Azauracils from Pfizer useful as thyroid receptor ligands

May 14, 2001

Pfizer presents new glycogen phosphorylase inhibitors and potential uses

May 14, 2001

TPO mimetics in development at GSK

May 14, 2001

Successful completion of initial human trial for testosterone patch announced by 3M

May 14, 2001

Rabbit studies indicate safety, efficacy of KUR-1246 in threatened premature delivery

May 14, 2001

New agents from Takeda with the ability to enhance bone formation

May 11, 2001

MTP inhibitors designed at Boehringer Ingelheim for use in lipid and related disorders

May 11, 2001

Raloxifene examined for long-term effects on cognitive function

May 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...